![N-[(E)-3-[(2R,3S,4S)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide in PDB entry 3ozr, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3ozr_entity_4_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>3ozr</span> contains 1 copy of <span class='highlight'>N-[(E)-3-[(2R,3S,4S)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide</span>. Side view.")
![N-[(E)-3-[(2R,3S,4S)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide in PDB entry 3ozr, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3ozr_entity_4_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>3ozr</span> contains 1 copy of <span class='highlight'>N-[(E)-3-[(2R,3S,4S)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitro-benzamide</span>. Top view.")
Environment details NEW
OZR 224 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.